PLI schemes disburse ₹36,754 crore, driving ₹2.58 lakh crore in investment

DPIIT said production-linked incentive schemes had generated ₹23.79 lakh crore in production and sales, ₹15.53 lakh crore in exports and 14.57 lakh jobs by June 30. Electronics, pharma, medical devices and speciality steel are among the sectors seeing deeper domestic manufacturing.

— Source publishedFri, 25 Sept, 2026, 15:48 IST·First seen Fri, 25 Sept, 2026, 15:53 IST·Source BL · Consumer & Economy

What happened

DPIIT said PLI schemes had disbursed ₹36,754 crore by June 30, 2026, driving ₹2.58 lakh crore investment and ₹23.79 lakh crore production/sales. Electronics,

Key facts

  • ₹36,754 crore cumulative PLI incentives disbursed
  • ₹1.91 lakh crore approved PLI outlay
  • ₹2.58 lakh crore actual investment
  • ₹23.79 lakh crore production/sales
  • ₹15.53 lakh crore exports
  • 14.57 lakh jobs generated
  • ₹3.64 lakh crore pharmaceuticals sales
  • 1,931 pharmaceutical products domestically manufactured
  • 191 bulk drugs manufactured domestically for the first time
  • ₹6,475 crore domestic sales by medical-device PLI beneficiaries
  • ₹560 crore medical-device exports
  • ₹1,400 crore implant revenue
  • ₹19,000 crore investment by speciality steel companies

Why this matters

The manufacturing build-out creates partnership, supplier-acquisition and joint-venture opportunities in PLI-supported categories, particularly where retailers need more resilient India-based supply chains.

What to watch

  • Quarterly PLI disbursement pace versus the ₹1.91 lakh crore approved outlay.
  • New domestic capacity announcements, especially in electronics components, appliances, medical devices and specialty materials.
  • Changes in import duties, quality-control orders and local-content procurement rules.
  • Retail selling-price trends versus import parity in smartphones, appliances, consumer electronics and health devices.
  • Vendor concentration, component localization rates and evidence of supply-chain bottlenecks despite higher final-assembly output.
  • Map PLI-supported suppliers across consumer electronics, appliances, pharmacy, medical devices and steel-intensive home categories.
  • Rebid import-heavy private-label and exclusive-brand contracts using domestic manufacturing alternatives.
  • Build supplier scorecards for localization percentage, incentive eligibility, capacity expansion, quality performance and export commitments.
  • Use shorter domestic lead times to lower safety-stock requirements and improve in-stock availability in fast-moving categories.
  • Assess whether PLI-linked vendor capacity can support exclusive launches, festive inventory commitments and omnichannel fulfillment.

Also reported by